Cel Sci (CVM) Return on Equity [ROE] (2011 - 2026)
Cel Sci's Return on Equity [ROE] was -249.97% in fiscal Q3 2026 (quarter ended Jun 30, 2026), up 81.48 percentage points from -331.45% a year earlier but down 3.30 percentage points from the prior quarter.
Powered by 
Analysis
Cel Sci (CVM) Return on Equity [ROE] (2011 - 2026) Analysis & Trends
For FY2025 (ended Sep 30, 2025), Return on Equity [ROE] at Cel Sci came in at -172.15%, up 34.28 percentage points from FY2024.
- Return on Equity [ROE] shows a five-year change of +71.26 percentage points (FY2020 to FY2025).
- In earlier fiscal years, Return on Equity [ROE] was -206.43% in FY2024 (-64.54 pp), -141.89% in FY2023 (-58.14 pp), -83.75% in FY2022 (+11.17 pp) and -94.92% in FY2021 (+148.48 pp).
- Quarterly Return on Equity [ROE] has moved between -331.45% (fiscal Q3 2025) and -65.59% (fiscal Q4 2021) over five years.
- Compared with a year earlier, Return on Equity [ROE] has increased for four straight quarters, with an average year-over-year change of +4.34 percentage points over the last eight quarters.
- The best year-over-year quarter for Return on Equity [ROE] over five years was fiscal Q4 2021 (a gain of 83.40 percentage points); the worst was fiscal Q4 2023 (a drop of 123.05 percentage points).
- Per Business Quant data, CVM's Return on Equity [ROE] in the three fiscal quarters before Q3 2026 was -246.67% (Q2 2026), -171.87% (Q1 2026) and -215.91% (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 25.32% |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 7.21% |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 84.40% |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 21.39% |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 83.75% |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | -18.38% |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 4.97% |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 22.24% |
| 10 | Cel Sci | 3.69 Mn | -21.96 Mn | - | -249.97% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -249.97% |
| Mar 31, 2026 | -246.67% |
| Dec 31, 2025 | -171.87% |
| Sep 30, 2025 | -215.91% |
| Jun 30, 2025 | -331.45% |
| Mar 31, 2025 | -270.15% |
| Dec 31, 2024 | -221.38% |
| Sep 30, 2024 | -246.98% |
| Jun 30, 2024 | -243.22% |
| Mar 31, 2024 | -216.74% |
| Dec 31, 2023 | -234.38% |
| Sep 30, 2023 | -224.79% |
| Jun 30, 2023 | -188.66% |
| Mar 31, 2023 | -143.32% |
| Dec 31, 2022 | -118.70% |
| Sep 30, 2022 | -101.74% |
| Jun 30, 2022 | -84.88% |
| Mar 31, 2022 | -77.38% |
| Dec 31, 2021 | -72.40% |
| Sep 30, 2021 | -65.59% |
API Access
Cel Sci Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=CVM&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "CVM", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=CVM&period=max&api_key=YOUR_API_KEY");
const data = await res.json();